# Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

> **NCT00002976** · PHASE3 · TERMINATED · sponsor: **Gynecologic Oncology Group** · enrollment: 2108 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** conjugated estrogens

## Key facts

- **NCT ID:** NCT00002976
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-06
- **Primary completion:** 2006-07
- **Final completion:** —
- **Target enrollment:** 2108 (ESTIMATED)
- **Last updated:** 2013-04-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002976, "Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*